Concepedia
Statistics
Publications
12
Citations
875
H-Index
11
Active since
2017
Affiliations
Beth Israel Deaconess Medical Center(Current)
Dana-Farber Cancer Institute
Harvard University
University of Washington
University of California, Los Angeles
Carla Calagua is an author at Beth Israel Deaconess Medical Center specializing in medicine, prostate cancer, and oncology.
Publications per year
2017–2022
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 241 citations · Full text
Medicine, Molecular Biology, Oncology +12
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
Rana R. McKay, Huihui Ye, Wanling Xie et al. · Journal of Clinical Oncology · 2019 · 165 citations · Full text
Medicine, Surgery, Urology +17
Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
Carla Calagua, Joshua W. Russo, Yue Sun et al. · Clinical Cancer Research · 2017 · 88 citations
Medicine, Pharmacology, Cancer Pharmacology +12
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Adam G. Sowalsky, Huihui Ye, Manoj Bhasin et al. · Cancer Research · 2018 · 81 citations
Medicine, Oncology, Urology +17
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
Rana R. McKay, Wanling Xie, Huihui Ye et al. · The Journal of Urology · 2021 · 77 citations · Full text
1–5 of 12